Skip to content
★ Sign in to follow
Nipro Corporation logo

Nipro Corporation Stock: price and insider trades · Japan

ニプロ株式会社

JP·Mcap JP¥220.2BHealth Care

Nipro Corporation: what insiders have been doing

Headquartered in Kita-ku, Japan, Nipro Corporation belongs to the Health Care sector and traces its origins to 1948. Filings by its managers are published through EDINET (Japan FSA). Over the twelve months to 26 October 2026, 15 filings were filed, from 3 insiders.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

There has been no open-market purchase by an insider of Nipro Corporation for at least a year. Typically, a trade is published a median of 7 days after it takes place. That lag is the time during which only the insider knows about the trade.

With 15 filings in twelve months, the company is more active than the median of 3 filings across the 3,205 companies we follow on the same exchange.

This summary is built from EDINET (Japan FSA) disclosures alone and does not predict where the share price will go.

Insider Decl.
42
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

Analyst consensus: bullish or bearish?

Analysts rate Nipro Corporation Buy (bullish), based on 5 analysts. Average price target: JP¥1,956.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 11,179 of 26,911 companies
55.9
score / 100
Value
76
Quality
36
FCF yld24%
Earn yld6.0%
EV/EBITDA8.4x
ROE5.2%
Gross mgn32%
Net mgn2.0%
Debt/EBITDA6.2x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

JP¥1,350
Analyst consensus
5 analysts
Buy
JP¥1,600Target JP¥1,956(+45%)JP¥2,580
Income statement
RevenueJP¥660.5B
Gross profitJP¥208.3B32% margin
EBITDAJP¥103B16% margin
Net incomeJP¥13.5B2.1% margin
Valuation
PER (trailing)17.6x
P/Book0.8x
Beta-0.00
Balance sheet & cash
Market capJP¥220.2B
Total debtJP¥641.1B
Free Cash FlowJP¥54.7B
Debt / Equity193%
Profitability & ownership
ROE5.2%
ROA2.0%
% insiders9.9%
% institutions31.6%
Last declaration on 22 October 2026
Declarations42 total

25 of 42 declarations

About Nipro Corporation

Nipro Corporation is a Japanese company specializing in the healthcare and pharmaceutical sector. It is listed on the XTKS market.